332 related articles for article (PubMed ID: 12368622)
1. Modulation of murine allergic rhinosinusitis by CpG oligodeoxynucleotides.
Hussain I; Jain VV; Kitagaki K; Businga TR; O'Shaughnessy P; Kline JN
Laryngoscope; 2002 Oct; 112(10):1819-26. PubMed ID: 12368622
[TBL] [Abstract][Full Text] [Related]
2. Local therapy with CpG motifs in a murine model of allergic airway inflammation in IFN-beta knock-out mice.
Matheu V; Treschow A; Teige I; Navikas V; Issazadeh-Navikas S
Respir Res; 2005 Mar; 6(1):25. PubMed ID: 15748290
[TBL] [Abstract][Full Text] [Related]
3. Intranasal administration of CpG oligodeoxynucleotides reduces lower airway inflammation in a murine model of combined allergic rhinitis and asthma syndrome.
Li HT; Zhang TT; Chen ZG; Ye J; Liu H; Zou XL; Wang YH; Yang HL
Int Immunopharmacol; 2015 Sep; 28(1):390-8. PubMed ID: 26163938
[TBL] [Abstract][Full Text] [Related]
4. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model.
Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB
Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650
[TBL] [Abstract][Full Text] [Related]
5. Modification of allergic inflammation in murine model of rhinitis by different bacterial ligands: involvement of mast cells and dendritic cells.
Yamamoto K; Kawamura I; Ito J; Mitsuyama M
Clin Exp Allergy; 2006 Jun; 36(6):760-9. PubMed ID: 16776677
[TBL] [Abstract][Full Text] [Related]
6. Immunostimulatory sequence oligdeoxynucleotide/cholera toxin B conjugate: a novel allergen-independent intranasal vaccine for allergic rhinitis.
Won TB; Quan SH; Kim DY; Rhee CS; Lee CH
Ann Allergy Asthma Immunol; 2009 Apr; 102(4):314-22. PubMed ID: 19441603
[TBL] [Abstract][Full Text] [Related]
7. CpG ODN mediated prevention from ovalbumin-induced anaphylaxis in mouse through B cell pathway.
Xu W; Tamura T; Takatsu K
Int Immunopharmacol; 2008 Feb; 8(2):351-61. PubMed ID: 18182251
[TBL] [Abstract][Full Text] [Related]
8. [The effects of CpG-oligodeoxynucleotides on airway remodeling in chronic asthmatic mice].
Jie ZJ; Jin ML; Cai YY; Yuan ZH; Hu YW; Xu Y; Ren T; Yang ZH
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep; 29(9):612-6. PubMed ID: 17129469
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of airway eosinophilia and pulmonary pathology in a mouse model of allergic asthma by the live vaccine strain of Francisella tularensis.
KuoLee R; Zhou H; Harris G; Zhao X; Qiu H; Patel GB; Chen W
Clin Exp Allergy; 2008 Jun; 38(6):1003-15. PubMed ID: 18307525
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel Ag-specific immunotherapy using CpG oligodeoxynucleotides in a new, unique mouse cutaneous eosinophilic inflammation model.
Kootiratrakarn T; Fujimura T; Sano K; Okuyama R; Aiba S; Tagami H; Terui T
Eur J Immunol; 2005 Nov; 35(11):3277-86. PubMed ID: 16245360
[TBL] [Abstract][Full Text] [Related]
11. CpG-ODN inhibits airway inflammation at effector phase through down-regulation of antigen-specific Th2-cell migration into lung.
Ashino S; Wakita D; Zhang Y; Chamoto K; Kitamura H; Nishimura T
Int Immunol; 2008 Feb; 20(2):259-66. PubMed ID: 18156622
[TBL] [Abstract][Full Text] [Related]
12. Modulation of ovalbumin-induced Th2 responses by second-generation immunomodulatory oligonucleotides in mice.
Zhu FG; Kandimalla ER; Yu D; Tang JX; Agrawal S
Int Immunopharmacol; 2004 Jul; 4(7):851-62. PubMed ID: 15182725
[TBL] [Abstract][Full Text] [Related]
13. Five-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates poly (I:C)-induced airway inflammation in a murine model of asthma.
Kim TB; Kim SY; Moon KA; Park CS; Jang MK; Yun ES; Cho YS; Moon HB; Lee KY
Clin Exp Allergy; 2007 Nov; 37(11):1709-19. PubMed ID: 17877757
[TBL] [Abstract][Full Text] [Related]
14. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
[TBL] [Abstract][Full Text] [Related]
15. An antigen-independent but not antigen-specific T(H)1 response provides protection in the murine airway inflammation model.
Burger MS; Zuleger CL; Chu Q; Gao X; Payne LG; Chen D
J Allergy Clin Immunol; 2004 Dec; 114(6):1301-8. PubMed ID: 15577827
[TBL] [Abstract][Full Text] [Related]
16. Airway inflammation and adjuvant effect after repeated airborne exposures to di-(2-ethylhexyl)phthalate and ovalbumin in BALB/c mice.
Larsen ST; Hansen JS; Hansen EW; Clausen PA; Nielsen GD
Toxicology; 2007 Jun; 235(1-2):119-29. PubMed ID: 17462807
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory effects of CpG oligodeoxynucleotides on house dust mite-induced airway inflammation in mice.
Hirose I; Tanaka H; Takahashi G; Wakahara K; Tamari M; Sakamoto T; Kojima S; Inagaki N; Nagai H
Int Arch Allergy Immunol; 2008; 147(1):6-16. PubMed ID: 18446048
[TBL] [Abstract][Full Text] [Related]
19. Prenatal initiation of endotoxin airway exposure prevents subsequent allergen-induced sensitization and airway inflammation in mice.
Gerhold K; Avagyan A; Seib C; Frei R; Steinle J; Ahrens B; Dittrich AM; Blumchen K; Lauener R; Hamelmann E
J Allergy Clin Immunol; 2006 Sep; 118(3):666-73. PubMed ID: 16950286
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A
Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
